Rinko Ghosh
Keine laufenden Positionen mehr
Profil
Rinko Ghosh worked as the Chief Business Officer & Senior Vice President at Nektar Therapeutics from 2010 to 2014, and as the President & Chief Business Officer at Symic Bio, Inc. from 2016 to 2018.
Ghosh holds an MBA from the University of Pennsylvania, a graduate degree from Vanderbilt University, and an undergraduate degree from the Indian Institute of Technology Bombay.
Ehemalige bekannte Positionen von Rinko Ghosh
| Unternehmen | Position | Ende |
|---|---|---|
Symic Bio, Inc.
 Symic Bio, Inc. BiotechnologyHealth Technology Symic Bio, Inc. develops new category of therapeutics. The company studies treatments for osteoarthritis and cardiovascular ailments. The firm developed a new therapeutic category of bioconjugates that directly target the extracellular matrix, the biologically active environment which plays critical roles for cell proliferation, migration, differentiation and survival. The company was founded by Kate Stuart and John Paderi in 2012 and is headquartered in San Francisco, CA. | Präsident | 01.01.2018 |
| NEKTAR THERAPEUTICS | Corporate Officer/Principal | 15.03.2014 |
Ausbildung von Rinko Ghosh
| University of Pennsylvania | Masters Business Admin |
| Indian Institute of Technology Bombay | Undergraduate Degree |
| Vanderbilt University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NEKTAR THERAPEUTICS | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Symic Bio, Inc.
Symic Bio, Inc. BiotechnologyHealth Technology Symic Bio, Inc. develops new category of therapeutics. The company studies treatments for osteoarthritis and cardiovascular ailments. The firm developed a new therapeutic category of bioconjugates that directly target the extracellular matrix, the biologically active environment which plays critical roles for cell proliferation, migration, differentiation and survival. The company was founded by Kate Stuart and John Paderi in 2012 and is headquartered in San Francisco, CA. | Health Technology |
